USANA Health Sciences (NYSE:USNA – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.15, Zacks reports. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.
USANA Health Sciences Stock Performance
Shares of USANA Health Sciences stock traded down $0.79 during midday trading on Tuesday, hitting $31.90. The company had a trading volume of 439,914 shares, compared to its average volume of 145,126. USANA Health Sciences has a 52-week low of $30.13 and a 52-week high of $50.32. The stock has a market capitalization of $607.96 million, a P/E ratio of 11.27, a P/E/G ratio of 0.93 and a beta of 0.87. The company has a 50 day moving average of $33.73 and a 200 day moving average of $36.68.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on USNA. Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. DA Davidson lifted their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. Finally, StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- How to Short Nasdaq: An Easy-to-Follow Guide
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Are Penny Stocks a Good Fit for Your Portfolio?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Investors Need to Know About Upcoming IPOs
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.